NLS Pharmaceutics Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.83
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.00
|
-0.54
|
-0.54
|
0.00%
|
|
2021-12-31
|
0.00
|
-1.00
|
-1.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.42
|
-0.42
|
0.00%
|
|
2021-03-31
|
0.00
|
-0.24
|
-0.24
|
0.00%
|
|
2020-12-31
|
0.00
|
-0.21
|
-0.21
|
0.00%
|
|
2020-09-30
|
0.00
|
-0.51
|
-0.51
|
0.00%
|
|
2020-06-30
|
0.00
|
-0.12
|
-0.12
|
0.00%
|
|
2020-03-31
|
0.00
|
-0.09
|
-0.09
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-09-30
|
-0.54
|
|
2021-12-31
|
-1.66
|
|
2020-12-31
|
-0.92
|
|
2019-12-31
|
-1.04
|
|
2018-12-31
|
-0.91
|
|
2017-12-31
|
-0.17
|